In the BioHarmony Drug Report Database

"Preview" Icon

Somatropin

Accretropin, Genotropin, Humatrope, Norditropin, Nutropin, Nutropin AQ, Omnitrope, Saizen, Serostim, Zomacton, Zorbtive/Serostim, NutropinAq (somatropin) is a protein pharmaceutical. Somatropin was first approved as Accretropin on 1986-10-16. It is used to treat cachexia, dwarfism, heart failure, noonan syndrome, and prader-willi syndrome amongst others in the USA. It has been approved in Europe to treat pituitary dwarfism, prader-willi syndrome, and turner syndrome. The pharmaceutical is active against growth hormone receptor.

 

Trade Name

 

NutropinAq
 

Common Name

 

somatropin
 

ChEMBL ID

 

CHEMBL1201621
 

Indication

 

cachexia, dwarfism, heart failure, noonan syndrome, pituitary dwarfism, prader-willi syndrome, turner syndrome
 

Drug Class

 

Tricyclic compounds; atropine derivatives; growth hormone derivatives

Image (chem structure or protein)

Somatropin structure rendering